CR-CP Life Science Fund
News,Biotech / MedTech,Singapore,Investments
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
July 8, 2021
Maybank lowers Sea’s earnings on softer margin
October 24, 2025
Partners Group exits Singapore-headquartered Apex Logistics
October 24, 2025
Maybank lowers Sea’s earnings on softer margin
October 24, 2025
Partners Group exits Singapore-headquartered Apex Logistics
October 24, 2025




